Search

Author/Creator Kingo, K.

1. European consensus statement on phenotypes of pustular psoriasis. (29th August 2017)

Authors:
Navarini, A.A.; Burden, A.D.; Capon, F.; Mrowietz, U.; Puig, L.; Köks, S.; Kingo, K.; Smith, C.; Barker, J.N.
Other Names:
Bachelez Hervé investigator.; Chiricozzi Andrea investigator.; Costanzo Antonio investigator.; Eyerich Kilian investigator.; French Lars E. investigator.; Ghoreschi Kamran investigator.; Gilliet Michel investigator.; Girolomoni Giampiero investigator.; Gniadecki Robert investigator.; Griffiths Ch...
Journal:
Journal of the European Academy of Dermatology and Venereology
Issue:
Volume 31:Number 11(2017)
Page Start:
1792
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Increased microRNA‐323‐3p in IL‐22/IL‐17‐producing T cells and asthma: a role in the regulation of the TGF‐β pathway and IL‐22 production. Issue 1 (29th April 2016)

Authors:
Kärner, J.; Wawrzyniak, M.; Tankov, S.; Runnel, T.; Aints, A.; Kisand, K.; Altraja, A.; Kingo, K.; Akdis, C. A.; Akdis, M.; Rebane, A.
Journal:
Allergy
Issue:
Volume 72:Issue 1(2017:Jan.)
Page Start:
55
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Response to IL‐17A inhibitors secukinumab and ixekizumab cannot be explained by genetic variation in the protein‐coding and untranslated regions of the IL‐17A gene: results from a multicentre study of four European psoriasis cohorts. (5th August 2019)

Authors:
van Vugt, L.J.; van den Reek, J.M.P.A.; Meulewaeter, E.; Hakobjan, M.; Heddes, N.; Traks, T.; Kingo, K.; Galluzzo, M.; Talamonti, M.; Lambert, J.; Coenen, M.J.H.; de Jong, E.M.G.J.
Journal:
Journal of the European Academy of Dermatology and Venereology
Issue:
Volume 34:Number 1(2020)
Page Start:
112
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. Secukinumab administration by pre‐filled syringe: efficacy, safety and usability results from a randomized controlled trial in psoriasis (FEATURE). (11th December 2014)

Authors:
Blauvelt, A.; Prinz, J.C.; Gottlieb, A.B.; Kingo, K.; Sofen, H.; Ruer‐Mulard, M.; Singh, V.; Pathan, R.; Papavassilis, C.; Cooper, S.; the FEATURE Study Group
Journal:
British journal of dermatology
Issue:
Volume 172:Number 2(2015:Feb.)
Page Start:
484
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. Secukinumab administration by pre‐filled syringe: efficacy, safety and usability results from a randomized controlled trial in psoriasis (FEATURE). (1st February 2015)

Authors:
Blauvelt, A.; Prinz, J.C.; Gottlieb, A.B.; Kingo, K.; Sofen, H.; Ruer‐Mulard, M.; Singh, V.; Pathan, R.; Papavassilis, C.; Cooper, S.
Journal:
British journal of dermatology
Issue:
Volume 172:Number 2(2015:Feb.)
Page Start:
484
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. Secukinumab demonstrates high efficacy and a favourable safety profile in paediatric patients with severe chronic plaque psoriasis: 52‐week results from a Phase 3 double‐blind randomized, controlled trial. (19th January 2021)

Authors:
Bodemer, C.; Kaszuba, A.; Kingo, K.; Tsianakas, A.; Morita, A.; Rivas, E.; Papanastasiou, P.; Keefe, D.; Patekar, M.; Charef, P.; Zhang, L.; Cafoncelli, S.; Papavassilis, C.
Journal:
Journal of the European Academy of Dermatology and Venereology
Issue:
Volume 35:Number 4(2021)
Page Start:
938
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

10. Secukinumab treatment leads to normalization of quality of life and disease symptoms in psoriasis patients with or without prior systemic psoriasis therapy: the PROSE study results. (1st July 2020)

Authors:
Augustin, M.; Dauden, E.; Mrowietz, U.; Konstantinou, M.P.; Gerdes, S.; Kingo, K.; Szepietowski, J.C.; Perrot, J.L.; Cuccia, A.; Rissler, M.; Gathmann, S.; Sieder, C.; Orsenigo, R.; Jagiello, P.; Bachhuber, T.
Journal:
Journal of the European Academy of Dermatology and Venereology
Issue:
Volume 35:Number 2(2021)
Page Start:
431
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗